0001387131-20-002656.txt : 20200306 0001387131-20-002656.hdr.sgml : 20200306 20200306164552 ACCESSION NUMBER: 0001387131-20-002656 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200306 DATE AS OF CHANGE: 20200306 EFFECTIVENESS DATE: 20200306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362215 FILM NUMBER: 20695433 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 D 1 primary_doc.xml X0708 D LIVE 0000887247 Adamis Pharmaceuticals Corp 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 858-997-2400 DELAWARE None CELLEGY PHARMACEUTICALS INC Corporation true Dennis J Carlo 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Director Robert O Hopkins 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Maxim Group LLC received sales commissions of $403,680 in connection with a concurrent registered direct offering by the Company. David J Marguglio 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Director Richard C Williams 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Director Howard C Birndorf 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Director Roshawn Blunt 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Director Ronald B Moss 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Karen K Daniels 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA CALIFORNIA 92130 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-02-21 false true true false 0 Maxim Group LLC 120708 None None 405 LEXINGTON AVENUE NEW YORK NY NEW YORK 10174 CA CALIFORNIA true 6090000 6090000 0 false 2 0 0 Maxim Group LLC received sales commissions of $403,680 in connection with a concurrent registered direct offering by the Company. 0 false Adamis Pharmaceuticals Corp /s/ Robert O. Hopkins Robert O. Hopkins Chief Financial Officer 2020-03-06